of the indecision that michael won't appearas the indecision that michael won't appear as a presenter on radio five live took us on von clinical trial results for a different pill this time developed by the us drug company pfizer, and, again, they're very, very strong, so this one, if you give this pill in the trial within three to five days of catching covid, then it cuts the risk of hospitalisation in that vulnerable group by 89%, which is very positive. there were no deaths at all from covid in the group that took the pill. in the group that took the dummy pill, the placebo in this trial, there were ten deaths. so you can see these are the kind products, the kind of treatments that are likely to be used going forward. they won't be for everyone, they will be for that very much smaller group of vulnerable, elderly people that might and if it from treatment like this. the uk has already purchased 250,000 causes of this pfizer drug. no details yet on when it will become available. you'd imagine that they will push for authorisation from the drug regulatory bodies very soon. the brexit minister, david frost, has said o